Novo Nordisk | NVO - Eps Ganancias Por Acción

Precio De Mercado
37.61
Cambio Diario
0.70 1.90%
Mensual
-5.43%
Anual
-42.25%
Q2 Expectativa
35.05

Fiscal Calendario Real Consenso Anterior Fecha
FY2025Q3 Sep/2025 0.92 6.12 May/06
FY2024Q3 Sep/2024 6.12 0.88 5.00 Nov/06
FY2024Q2 Jun/2024 4.49 4.32 Aug/07
FY2024Q1 Mar/2024 5.68 4.39 May/02
FY2023Q4 Dec/2023 0.72 0.67 6.02 Jan/31




Eps Cambio Fecha
ANI Pharmaceuticals USD 2.33 0.29 2025-12
Aurora Cannabis CAD -0.64 0.36 2025-12
Bausch Health Companies USD 1.08 0.08 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Canopy Growth CAD -0.05 0.03 2025-12
Corcept Therapeutics USD 0.2 0.04 2025-12
Drreddys Laboratories INR 0.16 0.04 2025-12
Eli Lilly USD 7.54 0.52 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Merck USD 2.04 0.54 2025-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Novartis USD 1.54 0.5 2025-12
Novo Nordisk DKK 6.04 1.54 2025-12
Novo Nordisk DKK 1.02 0.1 2025-12
Pacira USD 0.06 0.64 2025-12
Perrigo USD 0.77 0.03 2025-12
Phibro Animal Health USD 0.78 0.1 2025-12
Prestige Brands USD 1.14 0.07 2025-12
Sanofi EUR 1.53 1.38 2025-12
Supernus Pharmaceuticals USD -0.07 0.73 2025-12
Zoetis USD 1.48 0.22 2025-12